Song Fengli, Liao Ziling, Li Tong, Kang Ning, Li Zhiming, Fan Shufang, Liu Fengzhi
Department of Oncology, Beijing University of Chinese Medicine Third Affiliated Hospital.
Beijing University of Chinese Medicine, Beijing.
Medicine (Baltimore). 2020 Nov 25;99(48):e23318. doi: 10.1097/MD.0000000000023318.
Radiodermatitis is a common side effect of radiotherapy, but currently there is no standard treatment for its prevention. This study aimed to observe the effect of topical application of a paste based on traditional Chinese medicine, Jiawei Simiao Yongan Gao, on radiodermatitis caused by radiotherapy for patients with head and neck cancer.This was a retrospective cohort study of 40 patients with head and neck cancer evaluated during their radiotherapy. Of these, 20 patients were treated with Jiawei Simiao Yongan Gao on the irradiated skin from the beginning of radiotherapy (JSY group). The other 20 patients were given standard nursing (standard group). Acute skin reactions were classified according to the radiation-induced skin reaction assessment scale (RISRAS) and American radiation therapy oncology group (RTOG) acute toxicity grading criteria every 2 weeks, and adverse effects were recorded until the end of the radiotherapy.The two groups showed differences in severity of radiodermatitis. At 0 to 30 Gy, the skin reactions were similar in the two groups, while above 40 Gy the skin reactions were significantly lower grade in the JSY group (P < .05). At 0 to 20 Gy, there was no statistical significance (P > .05); but above 30 Gy they were lower in the JSY group (P < .05).Jiawei Simiao Yongan Gao effectively alleviated acute radiodermatitis caused by radiotherapy of head and neck cancer patients compared with standard nursing.
放射性皮炎是放射治疗的常见副作用,但目前尚无预防其发生的标准治疗方法。本研究旨在观察中药加味四妙永安膏局部应用对头颈部癌患者放疗所致放射性皮炎的疗效。
这是一项对40名头颈部癌患者放疗期间进行评估的回顾性队列研究。其中,20例患者从放疗开始即在照射皮肤上使用加味四妙永安膏(加味四妙永安膏组)。另外20例患者给予标准护理(标准组)。每2周根据放射性皮肤反应评估量表(RISRAS)和美国放射肿瘤学组(RTOG)急性毒性分级标准对急性皮肤反应进行分级,并记录不良反应直至放疗结束。
两组在放射性皮炎严重程度方面存在差异。在0至30 Gy时,两组皮肤反应相似,而在40 Gy以上时,加味四妙永安膏组皮肤反应分级明显较低(P<0.05)。在0至20 Gy时,差异无统计学意义(P>0.05);但在30 Gy以上时,加味四妙永安膏组较低(P<0.05)。
与标准护理相比,加味四妙永安膏能有效减轻头颈部癌患者放疗引起的急性放射性皮炎。